Maternal Immunization: Nature Meets NurtureReview Published on 2020-07-242023-08-30 Journal: Frontiers in Microbiology [Category] E형 간염, [키워드] antibody breast milk infant immunity maternal immunization Neonate Placenta Vaccine [DOI] 10.3389/fmicb.2020.01499 PMC 바로가기 [Article Type] Review
A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia4900 Published on 2020-07-242022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] antibody Case report China clinical feature clinically Community Computed tomography Control coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection cured diagnosed Diagnostic Criteria discharged Epidemic global pandemic healthy hospital Immunoglobulin Immunoglobulin G immunoglobulin M Infants infected with COVID-19 Infection lesson lung National Health Commission nebulized Neonatal nucleic acid amplification testing nucleic acid test occurred outbreak passive immunity Patient Pharyngeal swab plan Pneumonia positive Pregnancy Pregnant woman pregnant women prevention reported serum test Spread Symptom the WHO Treatment was tested with COVID-19 [DOI] 10.1097/MD.0000000000021335 PMC 바로가기 [Article Type] 4900
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody강력한 치료 항체에 의한 SARS-CoV-2 및 SARS-CoV의 중화를 위한 구조적 기반Report Published on 2020-07-232022-09-14 Journal: Science (New York, N.y.) [Category] Fulltext, SARS, 비임상, 진단, [키워드] administration against SARS-CoV Analysis antibody approved caused cellular complex conformational COVID-19 COVID-19 pandemic cross-protective demonstrated epitope Epitopes Fab fragment hACE2 highlight host cell humanized monoclonal antibody lung neutralization neutralize neutralizing antibody Prevent prevented pseudovirus public health crisis Pulmonary pathology RBD Receptor binding domain receptors reduced reported S trimer SARS-CoV SARS-CoV-2 the RBD the SARS-CoV-2 the SARS-CoV-2 virus therapeutic therapeutic intervention treating COVID-19 Treatment Vaccine Virological [DOI] 10.1126/science.abc5881 PMC 바로가기 [Article Type] Report
Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinicArticle Published on 2020-07-232022-11-01 Journal: GMS Hygiene and Infection Control [Category] COVID-19, [키워드] antibodies antibody Antibody titer assumed Cancer Care cleaning personnel cleaning staff company comparable Contact COVID-19 COVID-19 antibody COVID-19 virus elevated ELISA expected High-risk patients hospital hygiene hospitals IgA IgG IgG antibody titer in both group Inc incidence of COVID-19 increase in Infection mandatory oncology Patient patients PerkinElmer positive Prevalence prevalence of COVID-19 Prevent SARS-CoV-2 serology Seroprevalence strict hygiene measure study period Surveillance Swab tested virus detection was performed were measured [DOI] 10.3205/dgkh000353 PMC 바로가기 [Article Type] Article
COVID-19: A Review on Diagnosis, Treatment, and ProphylaxisReview Published on 2020-07-212022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS, [키워드] ACE2 addition Affect angiotensin Anti-inflammatory drugs antibody attenuate binding CD4+ T cell CD8+ clinical trial common cold contribute coronavirus 2 correlated country CoV COVID-19 infection develop diffusion drug Efficacy enzymatic activity Frequency functional healthcare identify immune immune system immunization in viral infect Infection involved measure Neutralizing antibodies outbreak outcome pandemic Patient Perspective Pneumonia positive prevention receptor Replication resources respiratory review SARS-CoV2 SARS-CoV2 infection severe respiratory syndrome severity single-stranded RNA virus Symptom the disease Tocilizumab Transcription Treatment turn Vaccine virus [DOI] 10.3390/ijms21145145 PMC 바로가기 [Article Type] Review
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infectionLetter Published on 2020-07-202022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] affected antibody antibody kinetics Contact ELISA Evidence Hospitalization IgA IgG IgG level individual infected patient Infection Mild moderate occurred pandemic physician positive positive IgG antibody Prevalence primary- and secondary-care physicians SARS-CoV-2 SARS-COV-2 infection Serological testing Symptom tested [DOI] 10.1080/22221751.2020.1793690 PMC 바로가기 [Article Type] Letter
Ivermectin: Potential Role as Repurposed Drug for COVID-19Brief Communications Published on 2020-07-192022-10-30 Journal: The Malaysian Journal of Medical Sciences : MJMS [Category] COVID-19, [키워드] 2019 novel coronavirus 2019-nCoV acute respiratory illness acute respiratory syndrome antibody antiparasitic approach being caused communicable coronavirus coronavirus disease Coronavirus disease 2019 country COVID-19 develop disease drug Drug repurposing effective effort information Ivermectin lack pandemic Pathogenesis pathway Potential proliferation rapid response Repurposed drug role SARS-CoV-2 spread to the disease therapeutic therapeutic agents therapeutic drug therapeutic option this new coronavirus Treatment Vaccine virus WHO World Health Organization [DOI] 10.21315/mjms2020.27.4.15 PMC 바로가기 [Article Type] Brief Communications
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observationArticle Published on 2020-07-172022-10-04 Journal: Scientific Reports [Category] SARS, 임상, 치료법, [키워드] antibody average carried cohort study COVID-19 Diseases Follow-up Health care indicate information Isolation management Medical research no significant difference observation Patient positive receiving recovered COVID-19 patient recovered patient recovered patients recurrence respond risk SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 viral RNA severely ill patient Sex symptomatic Treatment [DOI] 10.1038/s41598-020-68782-w PMC 바로가기 [Article Type] Article
Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 PatientsArticle Published on 2020-07-172022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] All the patient anti-SARS-CoV-2 antibodies antibody antibody production Asymptomatic collected COVID-19 COVID-19 patient ELISA ELISA test enzyme-linked immunosorbent evaluated exhibited group groups IgG IgG test immunoassay laboratory-confirmed Mild mild COVID-19 patient mild COVID-19 patients MOST neutralizing antibody optical Patient patients performed Pneumonia pneumonic produced Production serology severe COVID-19 patient symptomatic [DOI] 10.3390/jcm9072268 PMC 바로가기 [Article Type] Article
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2Research Published on 2020-07-162022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] Ability ACE2 acute respiratory syndrome aligned angiotensin-converting enzyme 2 antibody binding cause Cell common-cold conserved Coronavirus disease 2019 Coronaviruses COVID-19 cross-react cross-reactive cross-reactive antibodies cross-reactivity demonstrated detect diagnostic domain ELISA expressed expressing full length host cell receptor human infections immunogenic interact mAb mAbs mammalian cell MERS Middle East monoclonal antibody murine Novel coronavirus outbreak Part performed Protein raised recombinant S protein responsible Result S protein S2 subunit sandwich ELISA SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 infected cell SARS-CoV-2 research SARS-CoV-2 S protein SARS-CoV-2-infected cell sequence spike glycoprotein Spike protein syndrome tested the S protein while [DOI] 10.2807/1560-7917.ES.2020.25.28.2000291 PMC 바로가기 [Article Type] Research